Condition: Respiratory Syncytial Virus Infections · Sponsor: Shionogi
The main purpose of this study is to investigate the antiviral effect of S-337395 compared with placebo among nonhospitalized adult participants with high-risk factors for progression to severe RSV infection starting intervention within 72 hours of RSV symptom onset.
This description comes directly from the study's public registry record.
Shionogi Clinical Trials Administrator Clinical Support Help Line · 800-849-9707 · Shionogiclintrials-admin@shionogi.co.jp
Always discuss trial participation with your own doctor first.
| LA Universal Research Center, Inc. | Los Angeles, California, United States | Recruiting |
| Central Valley Research | Modesto, California, United States | Recruiting |
| Med Partnes, Inc - Elligo- PPDS | Toluca Lake, California, United States | Recruiting |
| Hope Clinical Trials - 3970 W Flagler St. | Coral Gables, Florida, United States | Recruiting |
| Beautiful Minds Clinical Research Center | Cutler Bay, Florida, United States | Recruiting |
| Doral Medical Research | Hialeah, Florida, United States | Recruiting |
| Southern Clinical Research | Miami, Florida, United States | Recruiting |
| LCC Medical Research - Miami - BTC - PPDS | Miami, Florida, United States | Recruiting |
| Global Health Clinical Trials | Miami, Florida, United States | Recruiting |
| Nuren Medical and Research Center | Miami, Florida, United States | Recruiting |
| Continental Clinical Research, LLC | Miami, Florida, United States | Recruiting |
| Dynamic Medical Research, LLC - Miami | Miami, Florida, United States | Withdrawn |
+ 71 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07214571